Zhang Xiaoxia, Wang Xiaohui, Yang Jingyu, Liu Xiaohua, Cai Lin, Zong Zhiyong
Center of Infectious Diseases, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, China.
Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
BMC Infect Dis. 2016 Aug 9;16:397. doi: 10.1186/s12879-016-1729-2.
A prospective study was performed to investigate the prevalence of colonization among ICU patients and to examine whether asymptomatic carriers were the source of subsequent C. difficile infection (CDI) and acquisition of toxigenic C. difficile.
Rectal swabs were collected from adult patients on admission to and at discharge from a 50-bed medical ICU of a major referral hospital in western China, from August to November 2014. Stools were collected from patients who developed ICU-onset diarrhea. Both swabs and stools were screened for tcdB (toxin B gene) by PCR. Samples positive to tcdB were cultured for C. difficile and isolates recovered were screened for tcdB and the binary toxin genes by PCR. Strain typing was performed using multilocus sequence typing and isolates belonging to the same sequence type (ST) were further typed using multiple-locus variable number tandem repeat analysis (MLVA).
During the 4-month period, rectal swabs were collected from 360 (90.9 %) out of 396 patients who were admitted to the ICU. Among the 360 patients, 314 had stayed in the ICU more than 3 days, of which 213 (73.6 %) had a rectal swab collected within the 3 days prior to discharge from ICU. The prevalence of toxigenic C. difficile colonization was 1.7 % (6 cases) and 4.3 % (10 cases) on admission and discharge, respectively. Only four (1.1 %) out of 360 patients had CDI, corresponding to 10.7 cases per 10,000 ICU days. None of the four cases had toxigenic C. difficile either on admission or at discharge. Toxigenic C. difficile isolates were recovered from all swabs and stool samples positive for tcdB by PCR and belonged to 7 STs (ST2, 3, 6, 37, 54, 103 and 129). None of the isolates belonging to the same ST had identical MLVA patterns. Binary toxin genes were detected in one ST103 isolate that caused colonization.
The prevalence of colonization with toxigenic C. difficile among patients on admission to ICU was low in our setting. ICU-acquired toxigenic C. difficile were not linked to those detected on admission. Active screening for toxigenic C. difficile may not be a resource-efficient measure in settings with a low prevalence of colonization.
开展一项前瞻性研究,以调查重症监护病房(ICU)患者中艰难梭菌定植的患病率,并检查无症状携带者是否为随后艰难梭菌感染(CDI)及产毒艰难梭菌感染的来源。
于2014年8月至11月,从中国西部一家大型转诊医院的50张床位的内科ICU成年患者入院时及出院时采集直肠拭子。从发生ICU获得性腹泻的患者中采集粪便。通过聚合酶链反应(PCR)对拭子和粪便进行毒素B基因(tcdB)筛查。对tcdB呈阳性的样本进行艰难梭菌培养,对培养出的分离株通过PCR进行tcdB和二元毒素基因筛查。采用多位点序列分型进行菌株分型,对属于同一序列类型(ST)的分离株进一步采用多位点可变数目串联重复分析(MLVA)进行分型。
在这4个月期间,从396名入住ICU的患者中的360名(90.9%)采集了直肠拭子。在这360名患者中,314名在ICU停留超过3天,其中213名(73.6%)在从ICU出院前3天内采集了直肠拭子。入院时和出院时产毒艰难梭菌定植的患病率分别为1.7%(6例)和4.3%(10例)。360名患者中仅有4名(1.1%)发生CDI,相当于每10000个ICU住院日有10.7例。这4例患者在入院时或出院时均无产毒艰难梭菌。通过PCR从所有tcdB呈阳性的拭子和粪便样本中培养出了产毒艰难梭菌分离株,这些分离株属于7种序列类型(ST2、3、6、37、54、103和129)。属于同一ST的分离株均无相同的MLVA模式。在1株引起定植的ST103分离株中检测到二元毒素基因。
在我们的研究环境中,ICU患者入院时产毒艰难梭菌定植的患病率较低。ICU获得性产毒艰难梭菌与入院时检测到的产毒艰难梭菌无关。在定植患病率较低的环境中,对产毒艰难梭菌进行主动筛查可能不是一项资源高效的措施。